17th September 2018 09:00 AM - 05:00 PM (GMT+01:00) Europe/London
Following two highly successful BIR/IDUG conferences in 2014 and 2016, this is an excellent opportunity to hear about the future of molecular radiotherapy dosimetry from an international faculty. There will be a poster session so that participants can present and discuss the work performed in other hospitals in addition to the talks. This conference would be useful for physicists, oncologists, radiologists, radiographers, and all people involved in molecular radiotherapy.
Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk
HERMES provides a comprehensive range of dosimetry software for molecular radiotherapy, including Hybrid Dosimetry & OLINDA/EXM for fast, efficient calculation of regional doses from whole-body planars and/or SPECT/CT, SUV-SPECT® quantitative reconstruction for any radionuclide and camera, and the new Hybrid 3D™ SIRT for personalized, voxel-based dosimetry for Selective Internal Radiation Therapy.
Philips Healthcare is a leading supplier of diagnostic imaging systems and related services. Following the recent programme of acquisitions the company offers a comprehensive porfolio of healthcare products including conventional X-ray systems, dedicated systems for cardiovascular and interventional procedures; CT and MRI scanners, nuclear medicine, radiation therapy planning, echocardiography, digital ultrasound, patient cardiac monitoring equipment and PACS. www.medical.philips.com
The healthcare market is in ongoing transition and we see healthcare providers worldwide drive consolidation, an increasingly "industrial" logic of healthcare delivery, and a shift from treating illness to managing health – ultimately looking for ways to improve outcomes while reducing costs. We aspire to be the partner to help achieve this goal. To live up to our ambition, we are determined to answer the questions that drive your business development. To overcome lack of specialised staff, ensure consistent outcomes across an organisation, increase competitiveness, avoid profitability risks, and implement growth strategies, we are your partner that you can rely on to stand out with clinical excellence, operational efficiency, and financial profitability. www.siemens.co.uk/healthcare